E3 Ligase
E3 ligases perform the last step in the ubiquitination cascade. They transfer the ubiquitin from the active site cysteine of E2 enzyme to the substrate lysine or N terminus. The loss of function or mis-targeting of the E3 ligases are associated with various cancer types.
Products Related to E3 Ligase(7)
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10940 | PRT 4165 | 31083-55-3 | >98.50% | |
Bmi1/Ring1A-mediated ubiquitination inhibitor | ||||
| GC11869 | SZL P1-41 | 222716-34-9 | >98.00% | |
SZL P1-41 is a specific inhibitor of S phase kinase-associated protein 2 (Skp2). | ||||
| GC15017 | NSC 624206 | 13116-77-3 | >98% | |
Ubiquitin-activating enzyme (E1) inhibitor | ||||
| GC15492 | SMER 3 | 67200-34-4 | >98.00% | |
SMER 3 is a small-molecule compound that selectively inhibits the SCFMet30 ubiquitin E3 ligase. | ||||
| GC25019 | 5-amino-2,4-dimethylpyridine (5A-DMP) | 1193-71-1 | >98% | |
| GC44291 | NAB 2 | 1504588-00-4 | >98.00% | |
NAB 2 is an inhibitor of α-synuclein-induced toxicity. | ||||
| GC50234 | N106 | 862974-25-2 | >98% | |
Activator of SUMO-activating enzyme, E1 ligase | ||||
